America in Transition Pages

Wednesday, May 18, 2016

FDA: Canagliflozin Linked to Amputations in Post-Marketing Trial

(MedPage Today) -- Monitoring committee suggests that CANVAS trial continue

from MedPage Today Washington Watch http://ift.tt/1NySJ6C
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)